Patch Test Preparations: Basis and State-of-the-Art Modern Diagnostic Tools for Contact Allergy

Area of Science:

• Dermatology
• Allergology
• Regulatory Science

Background:

• High-quality epicutaneous patch test (PT) preparations are essential for diagnosing allergic contact dermatitis.
• Current methods for identifying quality issues in PT products are limited, relying heavily on patient history and exposure.
• Quality deficiencies in PT preparations can lead to inaccurate diagnostic results, including false-negatives and false-positives.

Purpose of the Study:

• To review the European Union's marketing authorization (MA) requirements for epicutaneous patch test preparations.
• To highlight challenges faced by physicians regarding the quality and regulatory aspects of PT products.
• To emphasize the importance of regulatory compliance for ensuring the quality and reliability of PT preparations.

Main Methods:

• Review of European Union marketing authorization (MA) guidelines for medicinal products, specifically focusing on epicutaneous patch test preparations.
• Analysis of reported challenges and physician experiences with PT products within the EU regulatory framework.
• Discussion of factors influencing PT product quality, including active substance properties, preparation development, and manufacturing processes.

Main Results:

• Epicutaneous patch test preparations are regulated as medicinal products requiring marketing authorization (MA) in the EU.
• The MA process involves rigorous assessment of quality, safety, and efficacy by competent authorities.
• Continuous updates to product dossiers and adherence to regulatory requirements are crucial for maintaining product comparability and preventing deficiencies.

Conclusions:

• Compliance with EU regulatory requirements, including marketing authorization, is fundamental for ensuring the sustainable quality of epicutaneous patch test preparations.
• Harmonization of regulatory standards across the EU is necessary for the widespread availability of high-quality PT products.
• Addressing reported challenges and ensuring robust quality control are vital for reliable diagnostic testing in allergic contact dermatitis.